Oesophageal Cancer Trial, Recruiting (NCT06070376)

Oesophageal Cancer Trial, Recruiting NCT06070376 Sponsor: Instituto do Cancer do Estado de São Paulo Condition: Oesophageal Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06070376 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Oesophageal Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with advanced cancer of the esophagus (the tube connecting your throat to your stomach), whether or not you are currently receiving chemotherapy or radiation therapy
You have significant difficulty swallowing (rated above a certain level of severity) or you have an abnormal connection between your esophagus and your airways caused by the cancer
A team of doctors has recommended that a tube-like device (stent/prosthesis) be placed in your esophagus to help relieve swallowing difficulties

Who may not be able to join:

You are under 18 years of age
Your cancer originated somewhere other than the esophagus
The affected area of the esophagus measures less than 30mm (about 1.2 inches) in length
You have previously had a stent or prosthesis placed in your esophagus
Your tumor can be easily passed through with a standard endoscope (a thin camera tube about 9.8mm wide), meaning the narrowing may not be severe enough (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Fauze Maluf-Filho, PhD, Cancer Institute of the state of São Paulo (ICESP)

Phone: +5511991919014

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06070376

Sponsor: Instituto do Cancer do Estado de São Paulo

Phase: Not Applicable

Status: Recruiting

Condition: Oesophageal Cancer

Trial contact: +5511991919014

More information: https://clinicaltrials.gov/study/NCT06070376

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with advanced cancer of the esophagus (the tube connecting your throat to your stomach), whether or not you are currently receiving chemotherapy or radiation therapy
You have significant difficulty swallowing (rated above a certain level of severity) or you have an abnormal connection between your esophagus and your airways caused by the cancer
A team of doctors has recommended that a tube-like device (stent/prosthesis) be placed in your esophagus to help relieve swallowing difficulties

Who may not be able to join:

You are under 18 years of age
Your cancer originated somewhere other than the esophagus
The affected area of the esophagus measures less than 30mm (about 1.2 inches) in length
You have previously had a stent or prosthesis placed in your esophagus
Your tumor can be easily passed through with a standard endoscope (a thin camera tube about 9.8mm wide), meaning the narrowing may not be severe enough (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Instituto do Cancer do Estado de São Paulo

Registry

ClinicalTrials.gov

Start date

26 June 2023

Est. completion

26 February 2026

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Reinterventions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov